PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 328 participants.
Also called NCT02895737
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose supportive care
- Phase
- Not applicable
- Enrolled
- 328 participants
- Registry
-
NCT02895737
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT02895737. Randomized; single masking; primary purpose supportive care. Start 2016-12-28 (actual); primary completion 2021-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device
- Acronym
- PROTECT
- Condition
- Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves
- Intervention (Device)
- TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra
- Intervention (Device)
- TAVI: Edwards SAPIEN 3, Edwards Lifesciences, Edwards Sapien Ultra; Sentinel™ Cerebral Protection Systems
- Intervention (Device)
- TAVI: CoreValve® Evolut R™, CoreValve Medtronic
- Intervention (Device)
- TAVI: CoreValve® Evolut R™, CoreValve Medtronic; Sentinel™ Cerebral Protection Systems
- Lead sponsor
- Deutsches Herzzentrum Muenchen
Record details
- Record id
cardio:ct-nct02895737- Content hash
b7efc2061bb19ce40c5f4fb61426da17c9858f2cb4c98d040116a5de2938321e